Literature DB >> 421412

Malabsorption of hydrochlorothiazide following intestinal shunt surgery.

L Backman, B Beerman, M Groschinsky-Grind, D Hallberg.   

Abstract

Hydrochlorothiazide 775mg was administered orally to 5 patients who had undergone intestinal shunt operations for obesity 1.5 to 6 years previously. Postoperative weight loss averaged 53.4kg. The concentrations of hydrochlorothiazide in plasma and urine were determined with gas/liquid chromatography. The mean area under the plasma concentration time curve during 9h in 4 of the patients was 889ng/ml.h. Mean total urinary recovery of hydrochlorothiazide amounted to 23.0mg in the 5 patients, which corresponds to approximately half that seen in healthy volunteers. The gastrointestinal hydrochlorothiazide appears to be substantially reduced after intestinal shunt surgery.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 421412     DOI: 10.2165/00003088-197904010-00006

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  12 in total

1.  Oral contraceptives after intestinal bypass operations.

Authors:  E D Johansson; J G Kral
Journal:  JAMA       Date:  1976-12-20       Impact factor: 56.272

2.  Drug absorption and hepatic drug metabolism in patients with different types of intestinal shunt operation for obesity. A study with phenazone.

Authors:  P B Andreasen; P Danö; H Kirk; G Greisen
Journal:  Scand J Gastroenterol       Date:  1977       Impact factor: 2.423

3.  Small-intestinal length. An intraoperative study in obesity.

Authors:  L Backman; D Hallberg
Journal:  Acta Chir Scand       Date:  1974

4.  A bypass operation for obese hyperlipidemic patients.

Authors:  H Buchwald; R L Varco
Journal:  Surgery       Date:  1971-07       Impact factor: 3.982

5.  Surgical treatment of obesity.

Authors:  J H Payne; L T DeWind
Journal:  Am J Surg       Date:  1969-08       Impact factor: 2.565

6.  Some somatic complications after small intestinal bypass operations for obesity. Possible factors of significance in the incidence.

Authors:  L Backman; D Hallberg
Journal:  Acta Chir Scand       Date:  1975

7.  Bioavailability of two hydrochlorothiazide preparations.

Authors:  B Beermann; M Groschinsky-Grind; B Lindstrom
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

8.  The effect of jejunoileal bypass on the pharmacokinetics of digoxin in man.

Authors:  F I Marcus; E J Quinn; H Horton; S Jacobs; S Pippin; M Stafford; C Zukoski
Journal:  Circulation       Date:  1977-03       Impact factor: 29.690

9.  Absorption, metabolism, and excretion of hydrochlorothiazide.

Authors:  B Beermann; M Groschinsky-Grind; A Rosén
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

10.  Enhancement of the gastrointestinal absorption of hydrochlorothiazide by propantheline.

Authors:  B Beermann; M Groschinsky-Grind
Journal:  Eur J Clin Pharmacol       Date:  1978-07-30       Impact factor: 2.953

View more
  14 in total

Review 1.  Trends in oral drug bioavailability following bariatric surgery: examining the variable extent of impact on exposure of different drug classes.

Authors:  Adam S Darwich; Kathryn Henderson; Angela Burgin; Nicola Ward; Janet Whittam; Basil J Ammori; Darren M Ashcroft; Amin Rostami-Hodjegan
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

2.  Absorption of penicillin and paracetamol after small intestinal bypass surgery.

Authors:  S I Terry; J C Gould; J P McManus; L F Prescott
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of diuretics.

Authors:  B Beermann; M Groschinsky-Grind
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

4.  Michaelis-Menten absorption kinetics in drugs: - examples and implications.

Authors:  J H Wood; K M Thakker
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 5.  Clinical pharmacokinetics and endocrine disorders. Therapeutic implications.

Authors:  P O'Connor; J Feely
Journal:  Clin Pharmacokinet       Date:  1987-12       Impact factor: 6.447

Review 6.  Enteral drug absorption in patients with short small bowel : a review.

Authors:  René Severijnen; Nazila Bayat; Hans Bakker; Jules Tolboom; Ger Bongaerts
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 7.  Drug absorption in gastrointestinal disease and surgery. Clinical pharmacokinetic and therapeutic implications.

Authors:  P O Gubbins; K E Bertch
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

8.  Ampicillin and propylthiouracil pharmacokinetics in intestinal bypass patients followed up to a year after operation.

Authors:  J P Kampmann; H Klein; B Lumholtz; J E Mølholm Hansen
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

9.  Study of the bioavailability of pindolol in malabsorption syndromes.

Authors:  D Evard; J P Aubry; Y Le Quintrec; G Cheymol; A Cheymol
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

10.  Paracetamol absorption from different sites in the human small intestine.

Authors:  T Gramatté; K Richter
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.